gemcitabine has been researched along with n-methyladenosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Gu, HY; Hu, C; Huang, ZD; Lin, LL; Liu, ZZ; Wei, RX | 1 |
| Chen, S; Chen, ZW; Hu, JF; Huang, L; Huang, Y; Liao, CY; Pan, JJ; Shen, BY; Tian, YF; Wang, YD; Wang, ZW; Yang, C; Zhang, JQ | 1 |
3 other study(ies) available for gemcitabine and n-methyladenosine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
Topics: Adenosine; Antineoplastic Agents; Deoxycytidine; DNA Copy Number Variations; DNA Methylation; Docetaxel; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Kaplan-Meier Estimate; Sarcoma | 2021 |
SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Topics: Adenosine; Alternative Splicing; Deoxycytidine; DNA; Gemcitabine; Humans; Pancreatic Neoplasms; RNA, Long Noncoding; Serine-Arginine Splicing Factors | 2022 |